Kenvue Inc. (NYSE:KVUE) is listed among the 10 Best NYSE Dividend Stocks to Buy, highlighting its long-term value creation and position in the market. The company offers a variety of consumer health products, including popular brands like Tylenol, Neutrogena, and Listerine.

After separating from Johnson & Johnson, Kenvue Inc. (NYSE:KVUE) is focusing on enhancing brand relevance through digital tools and consumer insights. The company is also updating its supply chain and maintaining regulatory compliance, with recent efforts leading to improved productivity and operating margins.

As a recognized Dividend King, Kenvue Inc. (NYSE:KVUE) provides a quarterly dividend of $0.2075 per share, with a yield of 4.53%. This makes KVUE one of the top dividend stocks, having raised its dividend by 1.2% in July, post the separation from Johnson & Johnson.

While Kenvue Inc. (NYSE:KVUE) shows potential as an investment, some AI stocks may offer greater upside. For those seeking undervalued AI stocks, a free report on the best short-term AI stock is available. Explore opportunities beyond KVUE for potential growth and reduced risk in investments.

Read more at Yahoo Finance: Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks